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S u m m a r y
 One of the elements of therapeutic conduct aimed 
at avoiding the most severe cardiovascular events such as: 
heart attack or brain ischemic stroke is the treatment against 
thrombosis with the use of low molecular weight heparin, 
anticoagulants and anti – platelet drugs. This therapy is related 
with bleeding complications, occurring 2 -20% of the patients 
during treatment with anticoagulants. 
The aim of this study is to analyze the complications of 
anticoagulation with oral anticoagulants and low molecular 
weight heparin in the treatment of cardiac event in the early 
postoperative period after total hip replacement
In 5 day after right THA an event of atrial fibrillation (AF) 
occurred in 69 year old patient. According to cardiologist 
recommendation oral anticoagulant was administered to 
accompany previously used low molecular heparin on the 
14th day after surgery. At the moment when the therapeutic 
dose was achieved the patient presented severe pain which 
was localized in a right inguinal region and also in a surgically 
treated hip. The next day it was observed further increase in 
pain intensity as a right – sided femoral neuralgia accompanied 
by neurological deficits such as: progressive disorder of 
sensation on the front surface of the right thigh, weakness right 
knee reflex muscle, weakness in the active hip flexion and knee 
extension. In CT and ultrasonography examination the huge 
retroperitoneal hematoma in a right lumbar-illiac muscle was 
imaged. 
Severe hip pain after total hip replacement with progressive 
symptoms of peripheral nerve lesion obligated to do 
additional examination in the field of diagnostic imaging of 
the abdomen and requires a multidisciplinary evaluation. 
Taking into consideration indications and contraindications 
and an extensive clinical and laboratory monitoring are crucial 
conditions to prevent bleeding during anticoagulant therapy.
S t r e s z c z e n i e
 Jednym z elementów postępowania terapeutycznego 
mającym zapobiec najcięższym incydentom sercowo-
naczyniowym, takim jak zawał serca lub udar niedokrwienny 
mózgu jest leczenie przeciw zakrzepowe. Leczenie to wiąże 
się jednak z ryzykiem powikłań krwotocznych,  występujących 
u 2-20% chorych w czasie leczenia antykoagulantami. Celem 
pracy jest analiza powikłania leczenia przeciw zakrzepowego 
z zastosowaniem doustnych antykoagulantów i heparyny 
drobnocząsteczkowej w terapii incydentu sercowego we 
wczesnym okresie pooperacyjnym po endoprotezoplastyce 
stawu biodrowego.
 U chorej lat 69 po incydencie migotania przedsionków 
w 5 dobie pooperacyjnej, od 14 doby rozpoczęto leczenie p/
zakrzepowe z wykorzystaniem heparyny drobnocząsteczkowej 
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i antykoagulantów doustnych. W momencie uzyskania dawki 
terapeutycznej chora zgłosiła  silne dolegliwości bólowe 
zlokalizowane w okolicy prawej pachwiny i operowanego stawu 
biodrowego. W kolejnym dniu obserwowano dalsze narastanie 
natężenia bólu o charakterze rwy udowej prawostronnej 
z towarzyszącymi deficytami neurologicznymi: postępującym 
zaburzeniem czucia na przedniej powierzchni uda prawego, 
osłabieniem odruchu kolanowego prawego, osłabieniem siły 
mięśniowej w zakresie czynnego zgięcia stawu biodrowego 
i wyprostu stawu kolanowego. W wykonanych badaniach TK 
i USG stwierdzono duży krwiak zaotrzewnowy prawego dołu 
biodrowego. 
 Silny ból stawu biodrowego w okresie pooperacyjnym 
po endoprotezoplastyce stawu biodrowego z postępującymi 
objawami uszkodzenia nerwu obwodowego obliguje do 
wykonania badań dodatkowych w zakresie diagnostyki 
obrazowej jamy brzusznej i przestrzeni zaotrzewnowej oraz 
wymaga spojrzenia wielospecjalistycznego. Uwzględnienie 
wskazań i przeciwwskazań oraz dokładna kontrola kliniczna 
i laboratoryjna są nieodzownymi warunkami zapobiegania 
krwawienia w czasie leczenia antykoagulantami.
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ADMISSION
 
 Europe’s maximum total is approximately 490 
million inhabitants and it is perform every year about 7 million 
major surgery. Among the many potential postoperative 
complications there are cardiovascular diseases, which are 
the most important. The large operations incidence of cardiac 
deaths is 0.5 – 1.5% and non – fatal cardiac complications 
is 2.0 – 3.0%[1]. The risk of cardiovascular complications 
during major surgery is associated with a large incidence of 
cardiovascular diseases, which still have the first cause of 
death in Europe. This confirms the nature of the disease of 
civilization. Development and implementation of new ways 
of conduct therapeutic aim is to reduce the wear indicator. 
One of the elements of therapeutic conduct aimed at avoiding 
the most severe cardiovascular events such as: heart attack or 
brain ischemic stroke, is the treatment against thrombosis with 
the use of low molecular weight heparin, anticoagulants and 
anti – platelet drugs [2].
 It also has its implications for the surgical specialities 
as increases the risk of perioperative bleeding. Even without 
surgery anticoagulation is related with bleeding complications, 
occurring 2 -20% of the patients during treatment with 
anticoagulants and mortality averages is about 0.3% (0.01 – 
1.5%) [3].
 The aim of this study is to analyze the complications 
of anticoagulation with oral anticoagulants and low molecular 
weight heparin in the treatment of cardiac event in the early 
postoperative period after total hip replacement.
A CASE REPORT
 
 A 69–years old patient, admitted to the Orthopedic 
Clinic of the University Hospital number 1 in Bydgoszcz, 
to a planned total arthroplasty of the hip. The acceptance 
complained of ill not from cardio – vascular. Because of the 
recognized hypertension she was pharmacologically treated. 
Perioperative prophylaxis standard applied with the use of low 
molecular weight heparin. In 5 days after operation of typical 
incident occurred, and it was retrosternal pain during an attack 
of atrial fibrillation (AF). The recommended angiography, 
performed by the cardiologist of the radial artery showed 
no changes in the coronary vessels. Due to paroxysmal 
atrial fibrillation and scores on a scale CHA2DS2–VASc=3 
recommends the need to include oral anticoagulant. Because 
of the early post – operative period was increased at the 
beginning dose of low molecular weight heparin in therapeutic 
doses for preventive. The patient was transferred to a Branch 
of Early Rehabilitation to continue rehabilitation treatment. 
Within the next two weeks patient breathing exercises used 
kinesitherapy: active exercises in relieving lower limbs, active 
in relieving exercises with resistance exercises of the upper 
limb, proprioception exercises of motor control the body. The 
patient was independent and well – tolerated treatment. She 
moved with the help of two elbow crutches. On the 14th day 
after surgery that used heparin subcutaneously accompanied 
by oral anticoagulant.
 At the moment of the therapeutic dose a female 
presented severe pain which was localized around the right a 
female presented severe pain hip surgical. A clinical examination 
and radiological excluded sprain right hip replacement as well 
as other causes associated with implant. Initially enrolled 
analgesic drugs called NSAIDs. No improvement has forced 
the use of Tramadol, which first brought not – satisfying 
results and then Dolargan analgesic dose of 200mg/24 hours 
of relatively good analgesic effect. They take a picture of X – 
ray lumbar spine on which the radiologist stayed a completed 
circle L1 compression fracture and evidence of disc herniation. 
The next day it was observed further increase in pain intensity 
as a right – sided sciatic femoral accompanied by neurological 
deficits such as: progressive disorder of sensation on the front 
surface of the right thigh, weakness right knee reflex muscle 
weakness in the active hip flexion and knee extension. 
 We asked about neurosurgical consultation for 
suspected disc herniation paralytic L3 and L4. Commissioned 
by the neurosurgeon, performed a CT Scan of the L-S spine, in 
which revealed growing, old healed fracture of the L1 and multi 
– core discopathies – clinically irrelevant. Simultaneously, at 
the level of the iliac crest revealed a hematoma, the size of 
80 to 55 mm in the retroperitoneal space on the right hip in 
the muscle of the characteristic of bleeding into the kidneys 
space (at the right side) and bleeding to the pelvic fat tissue 
(Figure 1). This image was correlated with clinical symptoms 
presented by the patient. Abdominal ultrasound was performed 
which confirmed the retroperitoneal hematoma right iliac 
and said there is no fluid in the peritoneal cavity (Figure 
2). Morphology parameters did not show acute bleeding. 
Anticoagulant therapy was stopped to normalize blood clotting 
parameters. In made angio – CT of the abdomen showed no 
extravasation of contrast outside the lumen of blood. Due 
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to a decrease in pain intensity, there were no signs of active 
bleeding and the risk of further complications; it was decided 
to continue conservative treatment.
In addition, angio – CT in the right kidney were changing 
the diameter of 16 mm. Urological consultation excluded 
relationship changes in the kidney with retroperitoneal 
bleeding. 
Within the following 20 days of treatment, the patient 
experienced relief of pain on the right hip, active bends right hip 
and right knee extension in relieving, reduced disturbances of 
sensation in the right femoral nerve innervations, normalization 
of coagulation parameters and morphology. Functional status 
at discharge: patient would sit alone; she could walk with the 








 Atrial fibrillation occurs in the 1 – 2% general 
population and there is five – time more risks of stroke. 
Ischemic stroke associated with atrial fibrillation often ends in 
death and patients who survive them will experience a greater 
degree of disability. Incidence of AF in the perioperative period 
increases the risk of serious cardiovascular complications, 
because of risk of bleeding, because of a big does not allow 
the use of anticoagulation in therapeutic doses. Cardiology in 
the literature is just total of anticoagulation with rate control, 
and appropriate treatment of conditions is a key factor in 
preventing morbidity associated with atrial fibrillation [4,5,6].
 During anticoagulant therapy the risk of bleeding 
increases significantly, when the prolongation of the 
prothrombin time in patients than 4 times the value of the 
standard formulation (prothrombin pointer below 30%, INR 
above 5.0). The most common places of bleeding events 
during treatment with heparin are: bleeding into the intestines 
intramural hematoma retroperitoneal haemorrhage into the 
adrenal hematoma pleural and spontaneous splenic rupture.
 During treatment with oral anticoagulants the 
following may occur: haemorrhages central nervous system and 
retina, hematuria, gastrointestinal bleeding, haemopericardium 
of cardiac, tamponed bleeding into joint cavities, skin necrosis, 
bleeding into the adrenal glands and muscle hematomas. 
Bleeding most likely occur in the place of organic changes in 
organs [3,7,8].
 During anticoagulant therapy the doctor should 
keep in mind the factors of changing sensitivity in elderly 
on anticoagulants. In the elderly, often associated several 
diseases and they must take a variety of medications that can 
affect the stability of INR and increase the risk of bleeding. It 
is important to have a closer monitoring of anticoagulation to 
INR values were located as long as possible in the therapeutic 
range [2, 6, 9].
CONCLUSIONS
1.  Preventing morbidity associated with AF manifested by 
anticoagulation is related with risk of bleeding.
2.  Severe hip pain after total hip replacement with progressive 
symptoms of peripheral nerve damage obligated to do 
additional research in the field of diagnostic imaging of the 
abdomen and requires a multidisciplinary perspective.
3.  Taking into consideration, indications and contraindications 
and an extensive clinical and laboratory monitoring 
are indispensable condition to prevent bleeding during 
anticoagulant therapy.
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